Our Take
The piece correctly identifies that women's health audiences reject performative engagement, but offers no evidence that AI solves this—only that it could help brands listen better.
Why it matters
Women's health marketing has a credibility problem: audiences are primed to detect insincerity. Any vendor claiming AI fixes trust without addressing the underlying skepticism is missing the actual lever.
Do this week
Women's health marketers: audit your customer retention data by cohort and engagement type before licensing any AI tool—identify where you're actually losing trust, not where a vendor says AI helps.
The women's health engagement gap
BioPharma Dive published a sponsored perspective arguing that women's health brands have historically treated customers as discrete, episodic touchpoints rather than as long-term partners. The framing rests on a straightforward observation: women's health audiences have memory and skepticism for marketing that feels transactional or insincere.
The article positions AI as a tool to enable brands to move from episode-focused campaigns (promotional, seasonal, condition-reactive) to lifetime relationship models. The case is not that AI replaces authenticity, but that it can help brands identify patterns in what their audiences actually value and respond to across longer customer lifecycles.
Skepticism is a feature of the audience, not a bug to fix
Women's health marketing carries inherited baggage. Decades of pharmaceutical messaging, wellness over-selling, and sporadic outreach have trained the audience to detect what feels performative. A brand that suddenly invests in AI-powered personalization without addressing why customers stopped trusting them in the first place is solving a downstream problem.
The real question is not whether AI can segment or predict behavior better. It is whether better data collection and targeting restore credibility in a category where credibility is the limiting factor. The article does not claim AI solves trust; it claims AI helps brands keep attention longer. Those are different things.
How to read this for your own work
If you work in women's health marketing or product, the takeaway is not to license an AI tool and expect engagement to improve. The takeaway is to first measure what you're optimizing for. Are customers leaving because they don't feel seen? Because offers miss what they need? Because they don't believe you'll follow up?
AI can help you act on those answers once you know what they are. But if the underlying issue is that your brand has treated the relationship as episodic, no algorithm fixes the broken contract faster than consistency, transparency, and showing up when you said you would.